Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P. | Institution | 12 273 280 | 8,64% | US$ 216,13M | 2026-05-05 |
| New Enterprise Associates, Inc. | Institution | 12 273 280 | 8,64% | US$ 216,13M | 2026-05-05 |
| BlackRock, Inc. | Institution | 10 240 186 | 7,21% | US$ 180,33M | 2026-03-31 |
| Frazier Life Sciences Management, LP | Institution | 9 939 547 | 7,00% | US$ 175,04M | 2026-03-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 8 508 021 | 5,99% | US$ 149,83M | 2025-03-31 |
| FMR LLC | Institution | 8 037 349 | 5,66% | US$ 141,54M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 5 189 088 | 3,65% | US$ 91,38M | 2026-03-31 |
| Vivo Capital, LLC | Institution | 5 094 668 | 3,59% | US$ 89,72M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 4 978 567 | 3,51% | US$ 87,67M | 2026-03-31 |
| Marshall Wace LLP | Institution | 3 966 019 | 2,79% | US$ 69,84M | 2026-03-31 |
| Rubric Capital Management LP | Institution | 3 712 373 | 2,61% | US$ 65,37M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 3 298 430 | 2,32% | US$ 58,09M | 2026-03-31 |
| Viking Global Investors LP | Institution | 3 198 644 | 2,25% | US$ 56,33M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 3 102 058 | 2,18% | US$ 54,63M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 2 845 472 | 2,00% | US$ 50,11M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 2 778 231 | 1,96% | US$ 48,92M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 2 665 313 | 1,88% | US$ 46,94M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 2 622 306 | 1,85% | US$ 46,18M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 2 454 400 | 1,73% | US$ 43,22M | 2026-03-31 |
| Logos Global Management, L.P. | Institution | 2 400 000 | 1,69% | US$ 42,26M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 2 166 504 | 1,53% | US$ 38,15M | 2026-03-31 |
| Acorn Bioventures | Institution | 2 144 844 | 1,51% | US$ 37,77M | 2026-03-31 |
| Artia Global Partners LP | Institution | 2 013 602 | 1,42% | US$ 35,46M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 2 000 172 | 1,41% | US$ 35,22M | 2026-03-31 |
| Frontier Capital Management Co LLC | Institution | 1 994 292 | 1,40% | US$ 35,12M | 2026-03-31 |
| Artal Group S.A. | Institution | 1 786 867 | 1,26% | US$ 31,47M | 2026-03-31 |
| Pictet Asset Management Limited | Institution | 1 706 048 | 1,20% | US$ 30,04M | 2026-03-31 |
| Raymond James Financial, Inc. | Institution | 1 687 977 | 1,19% | US$ 29,73M | 2026-03-31 |
| Soleus Capital Management, L.P. | Institution | 1 620 000 | 1,14% | US$ 28,53M | 2026-03-31 |
| Pivotal BioVenture Partners LLC | Institution | 1 553 726 | 1,09% | US$ 27,36M | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 1 485 000 | 1,05% | US$ 26,15M | 2026-03-31 |
| Frazier Life Sciences XI, L.P. | Institution | 1 354 079 | 0,95% | US$ 23,85M | 2025-03-31 |
| Citadel Advisors LLC | Institution | 1 201 489 | 0,85% | US$ 21,16M | 2026-03-31 |
| Nan Fung Trinity (HK) Limited | Institution | 1 142 950 | 0,81% | US$ 20,13M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1 119 826 | 0,79% | US$ 19,72M | 2026-03-31 |
| Bank of America Corporation | Institution | 1 116 085 | 0,79% | US$ 19,65M | 2026-03-31 |
| F. L. Putnam Investment Management Co. | Institution | 1 063 301 | 0,75% | US$ 18,72M | 2026-03-31 |
| Rosalind Master Fund L.P. | Institution | 1 062 500 | 0,75% | US$ 18,71M | 2025-02-13 |
| Woodline Partners LP | Institution | 1 000 782 | 0,70% | US$ 17,62M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 968 588 | 0,68% | US$ 17,06M | 2026-03-31 |
| NEA 18 Venture Growth Equity, L.P. | Institution | 948 948 | 0,67% | US$ 16,71M | 2026-05-05 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
